{"title_page": "M\u00fcge \u00c7evik", "text_new": "{{short description|Turkish physician, infectious disease researcher and science communicator}}\n{{Infobox scientist\n| name              = M\u00fcge \u00c7evik\n| alma_mater        = [[Ege University]] <br> [[London School of Hygiene & Tropical Medicine]] <br> [[University College London]]\n| workplaces        = [[University of St Andrews]] <br> [[Chelsea and Westminster Hospital]]\n| known_for         = Medical virology <br> Science communication\n| image             = Muge Cevik.jpg\n}}\n\n'''M\u00fcge \u00c7evik''' is a physician, infectious diseases researcher and science communicator at the [[University of St Andrews]]. Her research considers [[HIV]], [[viral hepatitis]], emerging infections and tropical infections in [[Developing country|developing countries]]. During the [[COVID-19 pandemic]], alongside working on the front lines of the response, \u00c7evik was an advisor to the [[Chief Medical Officer (United Kingdom)|Chief Medical Officer]] of [[Scotland]] and the [[World Health Organization|World Health Organisation]].\n\n== Early life and education ==\n\u00c7evik is from Turkey. She studied medicine at the [[Ege University]]. As a medical student, \u00c7evik was involved with projects and youth organisations related to sexual health.<ref>{{Cite web|title=YCSRR Annual Report|url=http://www.youthcoalition.org/wp-content/uploads/Annaul-Report-2011_FINAL.pdf|last=|first=|date=2011|website=Youth Coallition|url-status=live|archive-url=|archive-date=|access-date=2020-05-12}}</ref><ref>{{Cite web|title=March 2011 iYAN Newsletter|url=https://advocatesforyouth.org/resources/newsletters/march-2011-iyan-newsletter/|website=Advocates for Youth|language=en|access-date=2020-05-12}}</ref> She served on the executive committee of the [[International Federation of Medical Students' Associations]] committee on [[reproductive health]].<ref>{{Cite web|title=Past Officials|url=https://ifmsa.org/past-officials/|website=International Federation of Medical Students' Associations (IFMSA)|language=en-US|access-date=2020-05-12}}</ref> In this capacity she worked with international organisations including [[United Nations Population Fund]] ([[United Nations Population Fund|UNFPA]]), [[Joint United Nations Programme on HIV/AIDS|UNAIDS]] and [[MTV]].<ref>{{Cite web|title=The SCORA Manual|url=https://issuu.com/ifmsa/docs/scora_manual/16|website=Issuu|language=en|access-date=2020-05-12}}</ref> Working with the [[United Nations Population Fund|UNFPA]], \u00c7evik delivered an international peer education training programme on sexual and reproductive health and rights.<ref>{{Cite web|title=SCORA Newsletter|url=https://issuu.com/ifmsa/docs/scoranewsbulletin|website=Issuu|language=en|access-date=2020-05-12}}</ref> \u00c7evik secured funding from the [[United States]] Embassy Youth Empowerment Grants to study [[HIV]] related stigma in health care settings. The outcomes of this research transformed curricula in eleven medical schools, and was presented at the [[International AIDS Conference]] in [[Mexico]].<ref>{{Cite web|title=Advocacy Project on HIV / AIDS in Medical Education|url=https://pozitifyasam.org/wp-content/uploads/Raporlar/tip.pdf|last=|first=|date=|website=|url-status=live|archive-url=|archive-date=|access-date=2020-05-12}}</ref> As a result of her advocacy, \u00c7evik was invited to join the [[UNAIDS]] programme coordinating board meeting .<ref>{{Cite web|title=UNAIDS Member States \u2013 Etats membres|url=http://data.unaids.org/pub/basedocument/2010/20091210_lop_final_en_and_en.pdf|last=|first=|date=2009-12-10|website=UNAIDS|url-status=live|archive-url=|archive-date=|access-date=2020-05-12}}</ref>\n[[File:Peer Education - Muge Cevik.jpg|thumb|\u00c7evik leading international peer-education programmes during her medical degree. ]]\nShe moved to [[London]] for her graduate studies, completing a master's degree in [[public health]] at the [[London School of Hygiene & Tropical Medicine]] and [[University College London]]. Her research considered [[HIV]] and other [[Sexually transmitted infection|sexually transmitted infections]].<ref name=\":0\">{{Cite web|title=Muge Cevik|url=https://www.journals.elsevier.com/clinical-microbiology-and-infection/editorial-board/muge-cevik|website=www.journals.elsevier.com|access-date=2020-05-11}}</ref> Her studies were sponsored by an international postgraduate scholarship from [[Rotary International]], which is awarded annually to distinguished leaders around the world.<ref>{{Cite web|title=Rotary Foundation Ambassadorial Scholars|url=https://www.rotaryinlondon.org/docs/c698b9f59498d74b0987a83abc511153.pdf|last=|first=|date=|website=Rotary in London|url-status=live|archive-url=|archive-date=|access-date=2020-05-11}}</ref> She was appointed a clinical researcher at [[Chelsea and Westminster Hospital]], where she completed her specialist training in internal medicine.<ref name=\":0\" /> \u00c7evik completed her [[Membership of the Royal Colleges of Physicians of the United Kingdom|Membership of the Royal Colleges of Physicians]] in 2015. She is currently undertaking doctoral research at the [[University of St Andrews]].<ref name=\":0\" />\n\n== Research and career ==\nIn 2016 \u00c7evik moved to [[Scotland]], where she joined [[NHS Lothian]] as a Senior Registrar in infectious diseases. Her research considers [[HIV]] and [[Tuberculosis]]. She has studied the epidemiology of these diseases in [[South Africa]], [[Uganda]], [[Zimbabwe]] and [[Tanzania]].<ref>{{Cite web|title=DR M\u00dcGE \u00c7EV\u0130K \u0130LE CORONA HAVADA KALMAZ - Haberi|url=https://www.sehrisakarya.com/saglik/dr-muge-cevik-ile-corona-havada-kalmaz-h1269.html|last=|first=|date=|website=Sehri Sakarya|language=tr|url-status=live|archive-url=|archive-date=|access-date=2020-05-12}}</ref> \u00c7evik is leading a [[Phase 3 clinical testing|phase 3 clinical trial]] that looks to reduce the treatment time for patients with [[Drug resistance|drug resistant]] [[tuberculosis]]. In 2020 she was awarded a Clinical Academic Training Fellowship, supported by the Chief Scientist Office Scotland, to establish the biological mechanisms that underpin a poor response to [[tuberculosis]] treatment in patients in [[Kampala]].\n\n=== Leadership during the [[COVID-19 pandemic]] ===\nDuring the [[COVID-19 pandemic]] \u00c7evik served an advisor to the [[Chief Medical Officer (United Kingdom)|Chief Medical Officer]] of [[Scotland]] and the [[World Health Organization|World Health Organisation]]. As part of this work, \u00c7evik is working on the management of misinformation surrounding [[Coronavirus disease 2019|coronavirus disease]].<ref>{{Cite web|title=Virolog Dr. M\u00fcge \u00c7evik ile koronavir\u00fcsle ilgili do\u011fru bilinen yanl\u0131\u015flar|url=https://medyascope.tv/2020/04/11/virolog-dr-muge-cevik-ile-koronavirusle-ilgili-dogru-bilinen-yanlislar/|date=2020-04-11|website=Medyascope|language=tr|access-date=2020-05-12}}</ref><ref>{{Cite web|title=Muge Cevik - Press/Media - University of St Andrews|url=https://risweb.st-andrews.ac.uk/portal/en/persons/muge-cevik(8f3ce432-59c0-45c0-ac90-bf2c808349ad)/clippings.html|website=risweb.st-andrews.ac.uk|access-date=2020-05-12}}</ref><ref>{{Cite web|title=BBC - Koronavir\u00fcs: \u0130zleyecilerimizin sorular\u0131n\u0131 Dr. M\u00fcge \u00c7evik yan\u0131tlad\u0131 - University of St Andrews|url=https://risweb.st-andrews.ac.uk/portal/en/clippings/bbc--koronavirus-izleyecilerimizin-sorularn-dr-muge-cevik-yantlad(6d5d82f1-5e70-4f90-ac19-2851802a2e07).html|website=risweb.st-andrews.ac.uk|access-date=2020-05-12}}</ref> Throughout the pandemic she provided expert commentary to the public about [[Coronavirus disease 2019|coronavirus disease]].<ref>{{Cite news|date=2020-03-30|title=Your COVID-19 questions, answered|language=ru|work=Reuters|url=https://ru.reuters.com/article/BigStory10/idUSKBN21F0S8|access-date=2020-05-11}}</ref><ref>{{Cite web|title=Popular science articles on Evrim A\u011fac\u0131|url=https://evrimagaci.org/mugecevik/icerikler|website=Evrim A\u011fac\u0131|language=tr|access-date=2020-05-12}}</ref> \n\n\u00c7evik made use of [[Twitter]] to keep the public up-to-date with [[coronavirus]]-related research.<ref>{{Cite web|title=Coronavirus: sourcing accurate, reliable information|url=https://www.publicmediaalliance.org/coronavirus-sourcing-accurate-reliable-information/|date=2020-02-03|website=Public Media Alliance|language=en-GB|access-date=2020-05-11}}</ref> She identified that, as of May 2020, evidence indicated that transmission often occurred after sustained close contact and indoors, such as within households, family gatherings, connected indoor environments such as restaurants and offices.<ref>{{Cite web|title=Coronavirus infecting people \u2018weeks earlier than thought\u2019|url=https://www.theaustralian.com.au/science/coronavirus-infecting-people-weeks-earlier-than-thought/news-story/068057853f63e986e2404d29e4a8617e|last=Magnay|first=Jaquelin|date=|website=www.theaustralian.com.au|url-status=live|archive-url=|archive-date=|access-date=2020-05-11}}</ref><ref>{{Cite web|title=Why experts think the chances of catching coronavirus outside are lower|url=https://inews.co.uk/news/coronavirus-catch-outside-indoors-why-get-covid-19-explained-2848865|website=inews.co.uk|language=en|access-date=2020-05-11}}</ref>  Cevik called for more comprehensive contact tracing data to better understand the transmission dynamics of [[SARS-CoV-2]]. Working with [[Colin McCowan]], Cevik investigated household transmission of [[SARS-CoV-2]] in Scotland.<ref>{{Cite web|title=Rapid Research in Covid -19 programme (RARC-19 programme) \u2013 Chief Scientist Office|url=https://www.cso.scot.nhs.uk/rarc19projects/|website=www.cso.scot.nhs.uk|access-date=2020-05-12}}</ref> \n\nWorking with the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), \u00c7evik has looked to transfer clinical studies related to [[Coronavirus disease 2019|coronavirus disease]] to developing countries. She created a series of guidelines for clinicians outlining how they should respond to [[SARS-CoV-2]].<ref name=\":1\">{{Cite journal|last=Cevik|first=Muge|last2=Bamford|first2=Connor|last3=Ho|first3=Antonia|date=2020-04-25|title=COVID-19 pandemic \u2013 A focused review for clinicians|url=http://dx.doi.org/10.1016/j.cmi.2020.04.023|journal=Clinical Microbiology and Infection|volume=|pages=|doi=10.1016/j.cmi.2020.04.023|issn=1198-743X|via=}}</ref> As part of her work with ISARIC, \u00c7evik looks to identify the risk factors for severe illness in patients with [[Comorbidity|Comorbidities]] such as [[HIV]]. She works with ISARIC on rapid scientific reviews that can inform government policy.<ref>{{Cite web|title=What is the duration and dynamics of viral shedding in various body fluids in coronaviruses?|url=https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=181914|last=|first=|date=|website=www.crd.york.ac.uk|url-status=live|archive-url=|archive-date=|access-date=2020-05-12}}</ref><ref>{{Cite web|title=What are the clinical outcomes for people living with HIV who are diagnosed with human coronavirus infection?|url=https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=176144|last=|first=|date=|website=www.crd.york.ac.uk|url-status=live|archive-url=|archive-date=|access-date=2020-05-12}}</ref> Writing in [[the BMJ]], \u00c7evik highlighted the importance of ensuring HIV status and testing is included in the management of COVID-19.<ref>{{Cite web|title=COVID-19 and HIV: Calling attention to the importance of ensuring HIV status and testing is included in the management of COVID-19|url=https://blogs.bmj.com/sti/2020/04/07/covid-19-and-hiv-calling-attention-to-the-importance-of-ensuring-hiv-status-and-testing-is-included-in-the-management-of-covid-19/|last=haustin|date=2020-04-07|website=Sexually Transmitted Infections|language=en-US|access-date=2020-05-12}}</ref>\n[[File:British HIV Association Conference, 2012.jpg|thumb|\u00c7evik presenting at the British HIV Association Conference (2012)|alt=]]\n\n=== Academic service ===\n\u00c7evik is Associate Editor of the [[Elsevier]] journal [[Clinical Microbiology and Infection]].<ref name=\":0\" /> She serves on the steering committee of the [[European Society of Clinical Microbiology and Infectious Diseases]] (ESCMID), as well as leading an [[Erasmus Programme]] project that looks to implement infectious diseases training in undergraduate medical education.<ref>{{Cite web|title=ESCMID: Steering Committee|url=https://www.escmid.org/profession_career/trainee_association_of_escmid/who_we_are/steering_committee/|website=www.escmid.org|access-date=2020-05-12}}</ref> She serves on the executive committees of the Scottish Microbiology & Virology Network and the [[British HIV Association]].<ref>{{Cite web|title=External Relations Subcommittee|url=https://www.bhiva.org/ExternalRelationsSubcommittee|website=www.bhiva.org|access-date=2020-05-11}}</ref> \n\nAlongside her academic research, \u00c7evik is interested in science communication and how physicians can best use [[social media]] to disseminate their research.<ref name=\":0\" /> She has made use of social media network analysis to understand how scientists and physicians use [[Twitter]].<ref>{{Cite journal|last=Cevik|first=M.|last2=Ong|first2=D. S. Y.|last3=Mackenzie|first3=G.|date=2019-12-01|title=How scientists and physicians use Twitter during a medical congress|url=http://www.sciencedirect.com/science/article/pii/S1198743X19302083|journal=Clinical Microbiology and Infection|language=en|volume=25|issue=12|pages=1561.e7\u20131561.e12|doi=10.1016/j.cmi.2019.04.030|issn=1198-743X}}</ref> Her interest in science communication resulted in her developing the [[BHIVA]] social media strategy. \n\n== Selected works and publications ==\n{{Scholia|author}}\n* {{cite journal|last=Vispo|first=Eugenia|last2=Cevik|first2=Muge|last3=Rockstroh|first3=Juergen K.|last4=Barreiro|first4=Pablo|last5=Nelson|first5=Mark|last6=Scourfield|first6=Andrew|last7=Boesecke|first7=Christoph|last8=Wasmuth|first8=Jan-Christian|last9=Soriano|first9=Vincent|date=15 April 2013|title=Genetic Determinants of Idiopathic Noncirrhotic Portal Hypertension in HIV-Infected Patients|url=https://academic.oup.com/cid/article/56/8/1117/310217|journal=Clinical Infectious Diseases|language=en|volume=56|issue=8|pages=1117\u20131122|doi=10.1093/cid/cit001|issn=1058-4838}}\n* {{cite journal|last=Cevik|first=M.|date=1 October 2019|title=Social media to engage, communicate and interact|url=https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(19)30401-X/abstract|journal=Clinical Microbiology and Infection|language=English|volume=25|issue=10|pages=1165\u20131166|doi=10.1016/j.cmi.2019.07.012|issn=1198-743X|pmid=31349004}}\n* {{cite journal|last=Adzic-Vukicevic|first=Tatjana|last2=Cevik|first2=Muge|last3=Poluga|first3=Jasmina|last4=Micic|first4=Jelena|last5=Rubino|first5=Salvatore|last6=Paglietti|first6=Bianca|last7=Barac|first7=Aleksandra|last8=Adzic-Vukicevic|first8=Tatjana|last9=Cevik|first9=Muge|last10=Poluga|first10=Jasmina|last11=Micic|first11=Jelena|date=17 January 2020|title=An exceptional case report of disseminated cryptococcosis in a hitherto immunocompetent patient|url=http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0036-46652020000100502&lng=en&nrm=iso&tlng=en|journal=Revista do Instituto de Medicina Tropical de S\u00e3o Paulo|volume=62|pages=|doi=10.1590/s1678-9946202062003|issn=0036-4665|pmc=6968789|pmid=31967211|via=}}\n* {{cite journal|last=Cevik|first=Muge|last2=Bamford|first2=Connor|last3=Ho|first3=Antonia|date=25 April 2020|title=COVID-19 pandemic \u2013 A focused review for clinicians|url=http://dx.doi.org/10.1016/j.cmi.2020.04.023|journal=Clinical Microbiology and Infection|volume=|pages=|doi=10.1016/j.cmi.2020.04.023|issn=1198-743X|via=}}\n\n== References ==\n{{Reflist}}\n\n==External links==\n* [https://www.st-andrews.ac.uk/medicine/people/mc349 Muge Cevik] at [[University of St Andrews School of Medicine]]\n* [https://risweb.st-andrews.ac.uk/portal/en/persons/muge-cevik(8f3ce432-59c0-45c0-ac90-bf2c808349ad).html Muge Cevik] at [[University of St Andrews]]\n\n{{Authority control}}\n{{DEFAULTSORT:Cevik, Muge}}\n[[Category:Living people]]\n[[Category:Year of birth missing (living people)]]\n[[Category:Coronavirus researchers]]\n[[Category:Turkish physicians]]\n[[Category:Alumni of University College London]]\n[[Category:Ege University alumni]]\n[[Category:Science communicators]]\n[[Category:Turkish women scientists]]\n", "text_old": "{{short description|Turkish physician, infectious disease researcher and science communicator}}\n{{Infobox scientist\n| name              = M\u00fcge \u00c7evik\n| alma_mater        = [[Ege University]] <br> [[London School of Hygiene & Tropical Medicine]] <br> [[University College London]]\n| workplaces        = [[University of St Andrews]] <br> [[Chelsea and Westminster Hospital]]\n| known_for         = Medical virology <br> Science communication\n| image             = Muge Cevik.jpg\n}}\n\n'''M\u00fcge \u00c7evik''' is a physician, infectious diseases researcher and science communicator at the [[University of St Andrews]]. Her research considers [[HIV]], [[viral hepatitis]], emerging infections and tropical infections in [[Developing country|developing countries]]. During the [[COVID-19 pandemic]], alongside working on the front lines of the response, \u00c7evik was an advisor to the [[Chief Medical Officer (United Kingdom)|Chief Medical Officer]] of [[Scotland]] and the [[World Health Organization|World Health Organisation]].\n\n== Early life and education ==\n\u00c7evik is from Turkey. She studied medicine at the [[Ege University]]. As a medical student, \u00c7evik was involved with projects and youth organisations related to sexual health.<ref>{{Cite web|title=YCSRR Annual Report|url=http://www.youthcoalition.org/wp-content/uploads/Annaul-Report-2011_FINAL.pdf|last=|first=|date=2011|website=Youth Coallition|url-status=live|archive-url=|archive-date=|access-date=2020-05-12}}</ref><ref>{{Cite web|title=March 2011 iYAN Newsletter|url=https://advocatesforyouth.org/resources/newsletters/march-2011-iyan-newsletter/|website=Advocates for Youth|language=en|access-date=2020-05-12}}</ref> She served on the executive committee of the [[International Federation of Medical Students' Associations]] committee on [[reproductive health]].<ref>{{Cite web|title=Past Officials|url=https://ifmsa.org/past-officials/|website=International Federation of Medical Students' Associations (IFMSA)|language=en-US|access-date=2020-05-12}}</ref> In this capacity she worked with with international organisations including [[United Nations Population Fund]] ([[United Nations Population Fund|UNFPA]]), [[Joint United Nations Programme on HIV/AIDS|UNAIDS]] and [[MTV]].<ref>{{Cite web|title=The SCORA Manual|url=https://issuu.com/ifmsa/docs/scora_manual/16|website=Issuu|language=en|access-date=2020-05-12}}</ref> Working with the [[United Nations Population Fund|UNFPA]], \u00c7evik delivered an international peer education training programme on sexual and reproductive health and rights.<ref>{{Cite web|title=SCORA Newsletter|url=https://issuu.com/ifmsa/docs/scoranewsbulletin|website=Issuu|language=en|access-date=2020-05-12}}</ref> \u00c7evik secured funding from the [[United States]] Embassy Youth Empowerment Grants to study [[HIV]] related stigma in health care settings. The outcomes of this research transformed curricula in eleven medical schools, and was presented at the [[International AIDS Conference]] in [[Mexico]].<ref>{{Cite web|title=Advocacy Project on HIV / AIDS in Medical Education|url=https://pozitifyasam.org/wp-content/uploads/Raporlar/tip.pdf|last=|first=|date=|website=|url-status=live|archive-url=|archive-date=|access-date=2020-05-12}}</ref> As a result of her advocacy, \u00c7evik was invited to join the [[UNAIDS]] programme coordinating board meeting .<ref>{{Cite web|title=UNAIDS Member States \u2013 Etats membres|url=http://data.unaids.org/pub/basedocument/2010/20091210_lop_final_en_and_en.pdf|last=|first=|date=2009-12-10|website=UNAIDS|url-status=live|archive-url=|archive-date=|access-date=2020-05-12}}</ref>\n[[File:Peer Education - Muge Cevik.jpg|thumb|\u00c7evik leading international peer-education programmes during her medical degree. ]]\nShe moved to [[London]] for her graduate studies, completing a master's degree in [[public health]] at the [[London School of Hygiene & Tropical Medicine]] and [[University College London]]. Her research considered [[HIV]] and other [[Sexually transmitted infection|sexually transmitted infections]].<ref name=\":0\">{{Cite web|title=Muge Cevik|url=https://www.journals.elsevier.com/clinical-microbiology-and-infection/editorial-board/muge-cevik|website=www.journals.elsevier.com|access-date=2020-05-11}}</ref> Her studies were sponsored by an international postgraduate scholarship from [[Rotary International]], which is awarded annually to distinguished leaders around the world.<ref>{{Cite web|title=Rotary Foundation Ambassadorial Scholars|url=https://www.rotaryinlondon.org/docs/c698b9f59498d74b0987a83abc511153.pdf|last=|first=|date=|website=Rotary in London|url-status=live|archive-url=|archive-date=|access-date=2020-05-11}}</ref> She was appointed a clinical researcher at [[Chelsea and Westminster Hospital]], where she completed her specialist training in internal medicine.<ref name=\":0\" /> \u00c7evik completed her [[Membership of the Royal Colleges of Physicians of the United Kingdom|Membership of the Royal Colleges of Physicians]] in 2015. She is currently undertaking doctoral research at the [[University of St Andrews]].<ref name=\":0\" />\n\n== Research and career ==\nIn 2016 \u00c7evik moved to [[Scotland]], where she joined [[NHS Lothian]] as a Senior Registrar in infectious diseases. Her research considers [[HIV]] and [[Tuberculosis]]. She has studied the epidemiology of these diseases in [[South Africa]], [[Uganda]], [[Zimbabwe]] and [[Tanzania]].<ref>{{Cite web|title=DR M\u00dcGE \u00c7EV\u0130K \u0130LE CORONA HAVADA KALMAZ - Haberi|url=https://www.sehrisakarya.com/saglik/dr-muge-cevik-ile-corona-havada-kalmaz-h1269.html|last=|first=|date=|website=Sehri Sakarya|language=tr|url-status=live|archive-url=|archive-date=|access-date=2020-05-12}}</ref> \u00c7evik is leading a [[Phase 3 clinical testing|phase 3 clinical trial]] that looks to reduce the treatment time for patients with [[Drug resistance|drug resistant]] [[tuberculosis]]. In 2020 she was awarded a Clinical Academic Training Fellowship, supported by the Chief Scientist Office Scotland, to establish the biological mechanisms that underpin a poor response to [[tuberculosis]] treatment in patients in [[Kampala]].\n\n=== Leadership during the [[COVID-19 pandemic]] ===\nDuring the [[COVID-19 pandemic]] \u00c7evik served an advisor to the [[Chief Medical Officer (United Kingdom)|Chief Medical Officer]] of [[Scotland]] and the [[World Health Organization|World Health Organisation]]. As part of this work, \u00c7evik is working on the management of misinformation surrounding [[Coronavirus disease 2019|coronavirus disease]].<ref>{{Cite web|title=Virolog Dr. M\u00fcge \u00c7evik ile koronavir\u00fcsle ilgili do\u011fru bilinen yanl\u0131\u015flar|url=https://medyascope.tv/2020/04/11/virolog-dr-muge-cevik-ile-koronavirusle-ilgili-dogru-bilinen-yanlislar/|date=2020-04-11|website=Medyascope|language=tr|access-date=2020-05-12}}</ref><ref>{{Cite web|title=Muge Cevik - Press/Media - University of St Andrews|url=https://risweb.st-andrews.ac.uk/portal/en/persons/muge-cevik(8f3ce432-59c0-45c0-ac90-bf2c808349ad)/clippings.html|website=risweb.st-andrews.ac.uk|access-date=2020-05-12}}</ref><ref>{{Cite web|title=BBC - Koronavir\u00fcs: \u0130zleyecilerimizin sorular\u0131n\u0131 Dr. M\u00fcge \u00c7evik yan\u0131tlad\u0131 - University of St Andrews|url=https://risweb.st-andrews.ac.uk/portal/en/clippings/bbc--koronavirus-izleyecilerimizin-sorularn-dr-muge-cevik-yantlad(6d5d82f1-5e70-4f90-ac19-2851802a2e07).html|website=risweb.st-andrews.ac.uk|access-date=2020-05-12}}</ref> Throughout the pandemic she provided expert commentary to the public about [[Coronavirus disease 2019|coronavirus disease]].<ref>{{Cite news|date=2020-03-30|title=Your COVID-19 questions, answered|language=ru|work=Reuters|url=https://ru.reuters.com/article/BigStory10/idUSKBN21F0S8|access-date=2020-05-11}}</ref><ref>{{Cite web|title=Popular science articles on Evrim A\u011fac\u0131|url=https://evrimagaci.org/mugecevik/icerikler|website=Evrim A\u011fac\u0131|language=tr|access-date=2020-05-12}}</ref> \n\n\u00c7evik made use of [[Twitter]] to keep the public up-to-date with [[coronavirus]]-related research.<ref>{{Cite web|title=Coronavirus: sourcing accurate, reliable information|url=https://www.publicmediaalliance.org/coronavirus-sourcing-accurate-reliable-information/|date=2020-02-03|website=Public Media Alliance|language=en-GB|access-date=2020-05-11}}</ref> She identified that, as of May 2020, evidence indicated that transmission often occurred after sustained close contact and indoors, such as within households, family gatherings, connected indoor environments such as restaurants and offices.<ref>{{Cite web|title=Coronavirus infecting people \u2018weeks earlier than thought\u2019|url=https://www.theaustralian.com.au/science/coronavirus-infecting-people-weeks-earlier-than-thought/news-story/068057853f63e986e2404d29e4a8617e|last=Magnay|first=Jaquelin|date=|website=www.theaustralian.com.au|url-status=live|archive-url=|archive-date=|access-date=2020-05-11}}</ref><ref>{{Cite web|title=Why experts think the chances of catching coronavirus outside are lower|url=https://inews.co.uk/news/coronavirus-catch-outside-indoors-why-get-covid-19-explained-2848865|website=inews.co.uk|language=en|access-date=2020-05-11}}</ref>  Cevik called for more comprehensive contact tracing data to better understand the transmission dynamics of [[SARS-CoV-2]]. Working with [[Colin McCowan]], Cevik investigated household transmission of [[SARS-CoV-2]] in Scotland.<ref>{{Cite web|title=Rapid Research in Covid -19 programme (RARC-19 programme) \u2013 Chief Scientist Office|url=https://www.cso.scot.nhs.uk/rarc19projects/|website=www.cso.scot.nhs.uk|access-date=2020-05-12}}</ref> \n\nWorking with the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), \u00c7evik has looked to transfer clinical studies related to [[Coronavirus disease 2019|coronavirus disease]] to developing countries. She created a series of guidelines for clinicians outlining how they should respond to [[SARS-CoV-2]].<ref name=\":1\">{{Cite journal|last=Cevik|first=Muge|last2=Bamford|first2=Connor|last3=Ho|first3=Antonia|date=2020-04-25|title=COVID-19 pandemic \u2013 A focused review for clinicians|url=http://dx.doi.org/10.1016/j.cmi.2020.04.023|journal=Clinical Microbiology and Infection|volume=|pages=|doi=10.1016/j.cmi.2020.04.023|issn=1198-743X|via=}}</ref> As part of her work with ISARIC, \u00c7evik looks to identify the risk factors for severe illness in patients with [[Comorbidity|Comorbidities]] such as [[HIV]]. She works with ISARIC on rapid scientific reviews that can inform government policy.<ref>{{Cite web|title=What is the duration and dynamics of viral shedding in various body fluids in coronaviruses?|url=https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=181914|last=|first=|date=|website=www.crd.york.ac.uk|url-status=live|archive-url=|archive-date=|access-date=2020-05-12}}</ref><ref>{{Cite web|title=What are the clinical outcomes for people living with HIV who are diagnosed with human coronavirus infection?|url=https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=176144|last=|first=|date=|website=www.crd.york.ac.uk|url-status=live|archive-url=|archive-date=|access-date=2020-05-12}}</ref> Writing in [[the BMJ]], \u00c7evik highlighted the importance of ensuring HIV status and testing is included in the management of COVID-19.<ref>{{Cite web|title=COVID-19 and HIV: Calling attention to the importance of ensuring HIV status and testing is included in the management of COVID-19|url=https://blogs.bmj.com/sti/2020/04/07/covid-19-and-hiv-calling-attention-to-the-importance-of-ensuring-hiv-status-and-testing-is-included-in-the-management-of-covid-19/|last=haustin|date=2020-04-07|website=Sexually Transmitted Infections|language=en-US|access-date=2020-05-12}}</ref>\n[[File:British HIV Association Conference, 2012.jpg|thumb|\u00c7evik presenting at the British HIV Association Conference (2012)|alt=]]\n\n=== Academic service ===\n\u00c7evik is Associate Editor of the [[Elsevier]] journal [[Clinical Microbiology and Infection]].<ref name=\":0\" /> She serves on the steering committee of the [[European Society of Clinical Microbiology and Infectious Diseases]] (ESCMID), as well as leading an [[Erasmus Programme]] project that looks to implement infectious diseases training in undergraduate medical education.<ref>{{Cite web|title=ESCMID: Steering Committee|url=https://www.escmid.org/profession_career/trainee_association_of_escmid/who_we_are/steering_committee/|website=www.escmid.org|access-date=2020-05-12}}</ref> She serves on the executive committees of the Scottish Microbiology & Virology Network and the [[British HIV Association]].<ref>{{Cite web|title=External Relations Subcommittee|url=https://www.bhiva.org/ExternalRelationsSubcommittee|website=www.bhiva.org|access-date=2020-05-11}}</ref> \n\nAlongside her academic research, \u00c7evik is interested in science communication and how physicians can best use [[social media]] to disseminate their research.<ref name=\":0\" /> She has made use of social media network analysis to understand how scientists and physicians use [[Twitter]].<ref>{{Cite journal|last=Cevik|first=M.|last2=Ong|first2=D. S. Y.|last3=Mackenzie|first3=G.|date=2019-12-01|title=How scientists and physicians use Twitter during a medical congress|url=http://www.sciencedirect.com/science/article/pii/S1198743X19302083|journal=Clinical Microbiology and Infection|language=en|volume=25|issue=12|pages=1561.e7\u20131561.e12|doi=10.1016/j.cmi.2019.04.030|issn=1198-743X}}</ref> Her interest in science communication resulted in her developing the [[BHIVA]] social media strategy. \n\n== Selected works and publications ==\n{{Scholia|author}}\n* {{cite journal|last=Vispo|first=Eugenia|last2=Cevik|first2=Muge|last3=Rockstroh|first3=Juergen K.|last4=Barreiro|first4=Pablo|last5=Nelson|first5=Mark|last6=Scourfield|first6=Andrew|last7=Boesecke|first7=Christoph|last8=Wasmuth|first8=Jan-Christian|last9=Soriano|first9=Vincent|date=15 April 2013|title=Genetic Determinants of Idiopathic Noncirrhotic Portal Hypertension in HIV-Infected Patients|url=https://academic.oup.com/cid/article/56/8/1117/310217|journal=Clinical Infectious Diseases|language=en|volume=56|issue=8|pages=1117\u20131122|doi=10.1093/cid/cit001|issn=1058-4838}}\n* {{cite journal|last=Cevik|first=M.|date=1 October 2019|title=Social media to engage, communicate and interact|url=https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(19)30401-X/abstract|journal=Clinical Microbiology and Infection|language=English|volume=25|issue=10|pages=1165\u20131166|doi=10.1016/j.cmi.2019.07.012|issn=1198-743X|pmid=31349004}}\n* {{cite journal|last=Adzic-Vukicevic|first=Tatjana|last2=Cevik|first2=Muge|last3=Poluga|first3=Jasmina|last4=Micic|first4=Jelena|last5=Rubino|first5=Salvatore|last6=Paglietti|first6=Bianca|last7=Barac|first7=Aleksandra|last8=Adzic-Vukicevic|first8=Tatjana|last9=Cevik|first9=Muge|last10=Poluga|first10=Jasmina|last11=Micic|first11=Jelena|date=17 January 2020|title=An exceptional case report of disseminated cryptococcosis in a hitherto immunocompetent patient|url=http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0036-46652020000100502&lng=en&nrm=iso&tlng=en|journal=Revista do Instituto de Medicina Tropical de S\u00e3o Paulo|volume=62|pages=|doi=10.1590/s1678-9946202062003|issn=0036-4665|pmc=6968789|pmid=31967211|via=}}\n* {{cite journal|last=Cevik|first=Muge|last2=Bamford|first2=Connor|last3=Ho|first3=Antonia|date=25 April 2020|title=COVID-19 pandemic \u2013 A focused review for clinicians|url=http://dx.doi.org/10.1016/j.cmi.2020.04.023|journal=Clinical Microbiology and Infection|volume=|pages=|doi=10.1016/j.cmi.2020.04.023|issn=1198-743X|via=}}\n\n== References ==\n{{Reflist}}\n\n==External links==\n* [https://www.st-andrews.ac.uk/medicine/people/mc349 Muge Cevik] at [[University of St Andrews School of Medicine]]\n* [https://risweb.st-andrews.ac.uk/portal/en/persons/muge-cevik(8f3ce432-59c0-45c0-ac90-bf2c808349ad).html Muge Cevik] at [[University of St Andrews]]\n\n{{Authority control}}\n{{DEFAULTSORT:Cevik, Muge}}\n[[Category:Living people]]\n[[Category:Year of birth missing (living people)]]\n[[Category:Coronavirus researchers]]\n[[Category:Turkish physicians]]\n[[Category:Alumni of University College London]]\n[[Category:Ege University alumni]]\n[[Category:Science communicators]]\n[[Category:Turkish women scientists]]\n", "name_user": "Arjayay", "label": "safe", "comment": "Duplicate word removed", "url_page": "//en.wikipedia.org/wiki/M%C3%BCge_%C3%87evik"}
